Jointly provided by
 |
This activity is supported by an educational grant from Novo Nordisk, Inc. |
Presented by ManagedCareHemo.com
Register now by clicking the link at the bottom of this page.
ManagedCareHemo.com Presents: Hemophilia Clinical and Collaborative Care Recommendations for Cost Savings in a Managed Care Setting
Track 1: Clinical Updates and Treatment Management Recommendations
Track 2: Collaborative and Comprehensive Care Recommendations
Live Webcast Dates
| TRACK | DAY | DATE | TIME |
| Track 2 | Thursday | October 15, 2015 | 2:00 pm - 3:30 pm EDT |
Target Audience
- Medical Directors, Pharmacy Directors, specialty pharmacists, and clinical pharmacists from health plans, HMOs, pharmacy benefit managers (PBMs), specialty pharmacy providers (SPPs), integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
- Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for hemophilia patients including: physicians, pharmacists, nurses, and case managers
Due to the advent of new and more costly treatment modalities, the management of pediatric and adult hemophilia patients has become more complicated for physicians, nurses, case managers, payers, specialty pharmacies, home health providers and family/caregivers. In the absence of a coordinated educational effort, the full benefits of care coordination have not yet been achieved. This educational initiative will provide managed care professionals with the latest information, presented by multi-disciplinary expert faculty, on the management of pediatric and adult hemophilia patients in health plan and other managed care settings. The hemophilia comprehensive care team is represented on the faculty panel, including Hemophilia Treatment Center (HTC) Medical Directors, HTC Nurse Coordinators, Managed Care Executives, and Specialty Pharmacy and Home Infusion Providers.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the effects of hemophilia with and without inhibitors on clinical, economic, and humanistic outcomes
- Evaluate current and emerging hemophilia therapies for children and adults, with and without inhibitors
- Employ a collaborative and comprehensive care model, including partnering HTCs, to optimize clinical and economic outcomes for health plan patients with hemophilia
- Recommend hemophilia management policies and protocols to optimize patient outcomes in a managed care and/or specialty pharmacy setting
Learning Goal/Purpose
This educational initiative is designed to provide managed care professionals with the latest clinical data and practice strategies in the management of pediatric and adult hemophilia patients in health plan and other managed care settings.
Our Distinguished Multi-disciplinary Faculty Presenters Include:
| Medical Directors | HTC Nurse Coordinators | Managed Care Executives | Specialty Pharmacy and Home Infusion Providers |
|
Steven W. Pipe, MD Director, Division of Pediatric Hematology and Oncology Pediatric Medical Director, Hemophilia and Coagulation Disorders Program University of Michigan Michael Tarantino, MD Professor of Pediatrics Division of Pediatric Hematology/Oncology University of Illinois College of Medicine Medical Director Bleeding & Clotting Disorders Institute |
Jennifer Maahs, RN, PNP, MSN Nurse Practitioner Indiana Hemophilia and Thrombosis Center Indianapolis, IN |
Ira Klein, MD, MBA, FACP Former Medical Director Aetna Vanita Pindolia, PharmD, BCPS Vice President, Ambulatory Clinical Pharmacy Programs Henry Ford Health System/Health Alliance Plan of Michigan Celynda G. Tadlock, PharmD, MBA Vice President, Pharmacy Business Development Aetna |
Joan Couden, BSN, RN National Director, Bleeding Disorder Program Walgreens Infusion Services, Hemophilia Terry Whiteside, RPh Director, Specialty Strategic Accounts CVS Caremark |
Agendas
Track 1: Clinical Updates and Treatment Management Recommendations
*All times Eastern Daylight Time
| Presentation | Live Webcast 1:
April 28 12:00pm - 1:30pm |
Live Webcast 2:
May 19 2:00pm - 3:30pm |
Live Webcast 3:
June 18 12:00pm - 1:30pm |
Live Webcast 4:
September 17 12:00pm - 1:30pm |
Live Webcast 5:
October 13 12:00pm - 1:30pm |
| Introduction | Moderator | ||||
| Hemophilia Clinical Updates: A Review of Current and Emerging Treatments | Steven W. Pipe, MD | Steven W. Pipe, MD | Steven W. Pipe, MD | Michael Tarantino, MD | Michael Tarantino, MD |
| Integrating Quality of Care Guidelines for Patients with Hemophilia | Vanita Pindolia, PharmD, BCPS | Celynda Tadlock, PharmD, MBA | Ira Klein, MD, MBA, FACP | Vanita Pindolia, PharmD, BCPS | Vanita Pindolia, PharmD, BCPS |
| Faculty Idea Exchange / Managed Care Case Studies | All | ||||
| Audience Question and Answer Session, Key Takeaways and Closing Comments | All | ||||
Track 2: Collaborative and Comprehensive Care Recommendations
*All times Eastern Daylight Time
| Presentation | Live Webcast 1:
April 30 12:00pm - 1:30pm |
Live Webcast 2:
May 20 1:00pm - 2:30pm |
Live Webcast 3:
June 11 2:00pm - 3:30pm |
Live Webcast 4:
September 30 12:00pm - 1:30pm |
Live Webcast 5:
October 15 2:00pm - 3:30pm |
| Introduction | Moderator | ||||
| Hemophilia Treatment Centers and the Comprehensive Care Model | Jennifer Maahs, RN, PNP, MSN | Jennifer Maahs, RN, PNP, MSN | Jennifer Maahs, RN, PNP, MSN | Jennifer Maahs, RN, PNP, MSN | Jennifer Maahs, RN, PNP, MSN |
| Collaborative Care Recommendations to Improve Care Coordination | Terry Whiteside, RPh | Terry Whiteside, RPh | Joan Couden, BSN, RN | Joan Couden, BSN, RN | Joan Couden, BSN, RN |
| Leveraging the Comprehensive Care Model for Cost Effective Outcomes | Ira Klein, MD, MBA, FACP | Vanita Pindolia, PharmD, BCPS | Ira Klein, MD, MBA, FACP | Celynda G. Tadlock, PharmD, MBA | Celynda G. Tadlock, PharmD, MBA |
| Faculty Idea Exchange / Managed Care Case Studies | All | ||||
| Audience Question and Answer Session, Key Takeaways and Closing Comments | All | ||||
Accreditation Statements
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources (MER), National Hemophilia Foundation, and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources designates these live activities for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Track 1: Clinical Updates and Treatment Management Recommendations -1.5 CME Credits
- Track 2: Collaborative and Comprehensive Care Recommendations -1.5 CME Credits
Pharmacy Credit
 |
Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
|
This activity is certified as Knowledge-based CPE.
Nursing Credit
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This CE activity provides 1.5 contact hours of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hours.
- Track 1: Clinical Updates and Treatment Management Recommendations -1.5 contact hours
- Track 2: Collaborative and Comprehensive Care Recommendations -1.5 contact hours
This program has been pre-approved by the Commission for Case Manager Certification to provide continuing education credit to Certified Case Managers (CCMs). The course is approved for 1.5 CE contact hours.
- Track 1: Clinical Updates and Treatment Management Recommendations -1.5 clock hours
- Track 2: Collaborative and Comprehensive Care Recommendations -1.5 clock hours
This program is approved by the National Association of Social Workers for 1.5 Social Work continuing education contact hours.
- Track 1: Approval #886699596 - 6329 for 1.5 Social Work continuing education contact hours
- Track 2: Approval #886699596 - 6330 for 1.5 Social Work continuing education contact hours
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.x, and Google Chrome 10 and up.
Fee Information
There is no fee for this educational activity.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
Click here to register